Eden Research (LON:EDEN) Hits New 12-Month Low – Here’s What Happened

Eden Research plc (LON:EDEN) shares reached a new 52-week low during trading on Monday . The company traded as low as GBX 2.13 and last traded at GBX 2.30, with a volume of 157282 shares traded. The stock had previously closed at GBX 2.29.

Eden Research Stock Up 0.3%

The firm’s 50-day simple moving average is GBX 2.57 and its 200 day simple moving average is GBX 3.18. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The company has a market cap of £12.27 million, a P/E ratio of -5.19 and a beta of 0.92.

Eden Research (LON:EDEN) last announced its quarterly earnings data on Wednesday, September 17th. The company reported GBX (0.25) EPS for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. On average, research analysts forecast that Eden Research plc will post -66.0000038 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Alexander John Abrey purchased 360,490 shares of the business’s stock in a transaction that occurred on Wednesday, September 17th. The shares were acquired at an average cost of GBX 3 per share, for a total transaction of £10,814.70. Also, insider Sean M. Smith acquired 390,624 shares of Eden Research stock in a transaction that occurred on Wednesday, September 17th. The shares were purchased at an average cost of GBX 3 per share, for a total transaction of £11,718.72. 4.46% of the stock is currently owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.